Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung

被引：0

作者：

Kim, Hye Ryun ^{[1
]}

Gridelli, Cesare ^{[2
]}

Kapur, Dinesh ^{[3
]}

Tufman, Amanda ^{[4
]}

Felip, Enriqueta ^{[5
]}

Velcheti, Vamsidhar ^{[6
]}

Kim, Yu Jung ^{[7
]}

Goetze, Thorsten ^{[8
]}

Lopez, Pilar Garrido ^{[9
]}

Corre, Romain ^{[10
]}

Penkov, Konstantin ^{[11
]}

Anjum, Rana ^{[12
]}

Di Pace, Brian ^{[12
]}

Liu, Wenlei ^{[12
]}

Borgovan, Theo ^{[12
]}

Ledger, Danielle ^{[12
]}

Carver, Jennifer ^{[12
]}

Waszak, Angela ^{[12
]}

Dhar, Arindam ^{[12
]}

Novello, Silvia ^{[13
]}

机构：

[1] Yonsei Univ, Coll Med, Seoul, South Korea

[2] SG Moscati Hosp, Juriquilla, Mexico

[3] Eastern Connecticut Hematol & Oncol, Norwich, CT USA

[4] Thorac Oncol Ctr Munich, Munich, Germany

[5] Vall dHebron Univ Hosp, Barcelona, Spain

[6] NYU Langone Hlth, New York, NY USA

[7] Seoul Natl Univ, Coll Med, Seoul, South Korea

[8] UCT Univ, Inst Clin Canc Res, Krankenhaus Nordwest, Canc Ctr, Frankfurt, Germany

[9] Hosp Univ Ramon & Cajal, Madrid, Spain

[10] Ctr Hosp Univ Rennes, Rennes, France

[11] Private Med Inst Euromedserv, St Petersburg, Russia

[12] GlaxoSmithKline, London, England

[13] Univ Turin, San Luigi Hosp, Turin, Italy

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

989

引用

页码：163 / 163

页数：1

共 50 条

[1] Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
Kim, H. R.
Gridelli, C.
Kapur, D.
Tufman, A.
Felip, E.
Velcheti, V.
Kim, Y. J.
Goetze, T. O.
Lopez, P. Garrido
Corre, R.
Penkov, K.
Anjum, R.
Di Pace, B.
Liu, W.
Borgovan, T.
Ledger, D.
Carver, J.
Waszak, A.
Dhar, A.
Novello, S.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S109 - S110
[2] Safety and efficacy of dostarlimab in patients (pts) with recurrent/advanced non-small cell lung cancer (NSCLC)
Subramanian, J.
Moreno, V.
Bosch-Barrera, J.
Pikiel, J.
Kristeleit, R.
Guo, W.
Danaee, H.
Im, E.
Roda, D.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S886 - S887
[3] Weekly docetaxel (TXT) and cisplatin (CIS) for chemonaive patients (Pts) with advanced non-small cell lung cancer (NSCLC)
Aisner, J
Geunsch, L
Schwarz, S
Zheng, L
Wojtaszek, C
Lutzker, S
[J]. LUNG CANCER, 2005, 49 : S233 - S233
[4] Trends in demographics and survival for patients (pts) with advanced non-small cell lung cancer (NSCLC).
Kubota, K.
Masuhara, H.
Hosoya, K.
Yoh, K.
Niho, S.
Goto, K.
Ohmatsu, H.
Nishiwaki, Y.
Saijo, N.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 392S - 392S
[5] Docetaxel in advanced non-small cell lung cancer
Wakelee, H
Ramalingam, S
Belani, CP
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 13 - 24
[6] Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).
Le, Xiuning
Paz-Ares, Luis G.
Van Meerbeeck, Jan
Viteri, Santiago
Galvez, Carlos Cabrera
Baz, David Vicente
Kim, Young-Chul
Kang, Jin-Hyoung
Schumacher, Karl-Maria
Karachaliou, Niki
Adrian, Svenja
Bruns, Rolf
Paik, Paul K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[7] Phase ii trial with Docetaxel in patients (PTS) with non small cell lung cancer (NSCLC)
Latreille, J
Laberge, F
Viallet, J
Maksymiuk, A
Shepherd, F
Gelman, K
Delorme, F
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1070 - 1070
[8] Docetaxel in the management of advanced non-small cell lung cancer
Miller, VA
[J]. SEMINARS IN ONCOLOGY, 1998, 25 (03) : 15 - 19
[9] Interstitial Lung Disease Associated with Docetaxel in Patients with Advanced Non-small Cell Lung Cancer
Tamiya, Akihiro
Naito, Tateaki
Miura, Satoru
Morii, Sakae
Tsuya, Asuka
Nakamura, Yukiko
Kaira, Kyoichi
Murakami, Haruyasu
Takahashi, Toshiaki
Yamamoto, Nobuyuki
Endo, Masahiro
[J]. ANTICANCER RESEARCH, 2012, 32 (03) : 1103 - 1106
[10] Celecoxib (CEL) and weekly docetaxel (DOC) in elderly or PS2 patients (pts) with advanced non-small cell lung cancer (NSCLC).
Chaplan, RA
Kalemkerian, GP
Wozniak, A
Shehadeh, N
Ruckdeschel, JC
Kraut, MJ
Heilbrun, L
Parchment, R
Gadgeel, SM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 641S - 641S

← 1 2 3 4 5 →